Ds Healthcare Group Comments on Recent Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Rodman & Renshaw Reinstates DS Healthcare (DSKX) at Buy
March 31, 2016 7:47 AM EDTRodman & Renshaw reinstated coverage on DS Healthcare (NASDAQ: DSKX) with a Buy rating and a price target of $1.50. Analyst Raghuram Selvaraju said clarity on accounting restatements indicates limited damage.
"In the wake of additional information disclosed by DS Healthcare regarding the scope and nature... More
